$11.32 Billion in Sales Expected for HCA Healthcare Inc (HCA) This Quarter

Analysts expect HCA Healthcare Inc (NYSE:HCA) to report sales of $11.32 billion for the current quarter, according to Zacks Investment Research. Nine analysts have provided estimates for HCA Healthcare’s earnings, with estimates ranging from $11.19 billion to $11.61 billion. HCA Healthcare reported sales of $10.62 billion in the same quarter last year, which indicates a positive year over year growth rate of 6.6%. The firm is scheduled to announce its next quarterly earnings report on Tuesday, May 1st.

According to Zacks, analysts expect that HCA Healthcare will report full year sales of $11.32 billion for the current fiscal year, with estimates ranging from $45.47 billion to $45.99 billion. For the next financial year, analysts anticipate that the business will post sales of $47.49 billion per share, with estimates ranging from $47.22 billion to $47.74 billion. Zacks’ sales averages are an average based on a survey of analysts that that provide coverage for HCA Healthcare.

HCA Healthcare (NYSE:HCA) last announced its quarterly earnings data on Tuesday, January 30th. The company reported $2.12 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.87 by $0.25. The business had revenue of $11.56 billion for the quarter, compared to analysts’ expectations of $11.19 billion. HCA Healthcare had a net margin of 4.89% and a negative return on equity of 49.49%. The firm’s quarterly revenue was up 8.7% compared to the same quarter last year. During the same period last year, the firm posted $1.80 earnings per share.

A number of analysts have weighed in on the stock. Argus set a $97.00 target price on shares of HCA Healthcare and gave the stock a “buy” rating in a research note on Wednesday, January 10th. Piper Jaffray Companies reaffirmed a “hold” rating and set a $101.00 target price on shares of HCA Healthcare in a research note on Tuesday, January 30th. Sanford C. Bernstein reaffirmed a “market perform” rating and set a $116.00 target price (up previously from $105.00) on shares of HCA Healthcare in a research note on Thursday, February 1st. ValuEngine raised shares of HCA Healthcare from a “hold” rating to a “buy” rating in a research note on Thursday, November 30th. Finally, BMO Capital Markets boosted their target price on shares of HCA Healthcare from $96.00 to $115.00 and gave the stock an “outperform” rating in a research note on Thursday, February 1st. They noted that the move was a valuation call. Three investment analysts have rated the stock with a sell rating, six have issued a hold rating and eighteen have given a buy rating to the company’s stock. The company presently has an average rating of “Buy” and an average price target of $104.50.

Shares of HCA Healthcare (HCA) opened at $101.00 on Tuesday. The firm has a market cap of $35,359.29, a price-to-earnings ratio of 14.81, a price-to-earnings-growth ratio of 1.01 and a beta of 0.48. HCA Healthcare has a one year low of $71.18 and a one year high of $106.84. The company has a debt-to-equity ratio of -6.58, a quick ratio of 1.36 and a current ratio of 1.62.

The firm also recently declared a quarterly dividend, which will be paid on Friday, March 30th. Stockholders of record on Thursday, March 1st will be issued a dividend of $0.35 per share. The ex-dividend date of this dividend is Wednesday, February 28th. This represents a $1.40 dividend on an annualized basis and a dividend yield of 1.39%.

In related news, insider Michael S. Cuffe sold 2,150 shares of the business’s stock in a transaction on Wednesday, November 22nd. The shares were sold at an average price of $78.00, for a total value of $167,700.00. Following the transaction, the insider now owns 12,476 shares in the company, valued at $973,128. The transaction was disclosed in a document filed with the SEC, which is available through this link. Also, insider Charles J. Hall sold 119,637 shares of the business’s stock in a transaction on Wednesday, February 14th. The shares were sold at an average price of $100.14, for a total transaction of $11,980,449.18. Following the completion of the transaction, the insider now owns 161,181 shares in the company, valued at approximately $16,140,665.34. The disclosure for this sale can be found here. In the last quarter, insiders have sold 396,106 shares of company stock worth $39,582,273. 2.90% of the stock is owned by company insiders.

A number of hedge funds have recently added to or reduced their stakes in the stock. Advisor Partners LLC lifted its holdings in HCA Healthcare by 13.5% in the fourth quarter. Advisor Partners LLC now owns 4,442 shares of the company’s stock valued at $413,000 after buying an additional 528 shares during the period. Parallel Advisors LLC lifted its holdings in HCA Healthcare by 76.2% in the fourth quarter. Parallel Advisors LLC now owns 1,337 shares of the company’s stock valued at $117,000 after buying an additional 578 shares during the period. Ladenburg Thalmann Financial Services Inc. lifted its holdings in HCA Healthcare by 8.3% in the third quarter. Ladenburg Thalmann Financial Services Inc. now owns 9,502 shares of the company’s stock valued at $756,000 after buying an additional 729 shares during the period. Amalgamated Bank lifted its holdings in HCA Healthcare by 2.3% in the third quarter. Amalgamated Bank now owns 33,983 shares of the company’s stock valued at $2,705,000 after buying an additional 754 shares during the period. Finally, Mutual of America Capital Management LLC lifted its holdings in HCA Healthcare by 2.2% in the third quarter. Mutual of America Capital Management LLC now owns 35,732 shares of the company’s stock valued at $2,844,000 after buying an additional 761 shares during the period. Institutional investors and hedge funds own 74.14% of the company’s stock.

ILLEGAL ACTIVITY NOTICE: This story was first posted by StockNewsTimes and is owned by of StockNewsTimes. If you are accessing this story on another domain, it was copied illegally and reposted in violation of US and international copyright and trademark laws. The correct version of this story can be accessed at https://stocknewstimes.com/2018/02/20/11-32-billion-in-sales-expected-for-hca-healthcare-inc-hca-this-quarter.html.

About HCA Healthcare

HCA Healthcare, Inc, formerly HCA Holdings, Inc, is a holding company. The Company, through its subsidiaries, owns and operates hospitals and related healthcare entities. As of December 31, 2016, the Company operated in two geographically organized groups, including the National and American Groups. As of December 31, 2016, the National Group included 84 hospitals, which were located in Alaska, California, Florida, southern Georgia, Idaho, Indiana, northern Kentucky, Nevada, New Hampshire, South Carolina, Utah and Virginia.

Get a free copy of the Zacks research report on HCA Healthcare (HCA)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for HCA Healthcare (NYSE:HCA)

Receive News & Ratings for HCA Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCA Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply